A Method for Interdicting the Development of Severe Jaundice in Newborns by Inhibiting the Production of Bilirubin

Pediatrics

Volumn 113, Issue 1 I, 2004, Pages 119-123

  Kappas, Attallah ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; HEME OXYGENASE; HEME OXYGENASE INHIBITOR; MESOPORPHYRIN TIN;

ANIMAL MODEL; BILIRUBIN BLOOD LEVEL; BILIRUBIN METABOLISM; BLOOD GROUP ABO INCOMPATIBILITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRIGLER NAJJAR SYNDROME; DISEASE SEVERITY; DRUG APPROVAL; DRUG EFFICACY; DRUG SAFETY; ENZYME INHIBITION; FOOD AND DRUG ADMINISTRATION; GILBERT DISEASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEMOCHROMATOSIS; HEREDITARY HEMOLYTIC ANEMIA; HUMAN; HYPERBILIRUBINEMIA; INFANT; JAUNDICE; MAJOR CLINICAL STUDY; MOUSE; NEWBORN; NEWBORN DISEASE; NEWBORN JAUNDICE; NONHUMAN; PHOTOTHERAPY; PREMATURITY; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RAT; REVIEW; SIDE EFFECT; TREATMENT OUTCOME;

BILIRUBIN; ENZYME INHIBITORS; FEMALE; HEME OXYGENASE (DECYCLIZING); HUMANS; INFANT, NEWBORN; JAUNDICE, NEONATAL; METALLOPORPHYRINS; PHOTOTHERAPY; RANDOMIZED CONTROLLED TRIALS;

EID: 0346340056     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.113.1.119     Document Type: Review

References (20)

1. Kappas A, Drummond GS. Control of heme metabolism with synthetic metalloporphyrins. J Clin Invest. 1986;77:335-339
2. Drummond GS, Kappas A. Prevention of neonatal hyperbilirubinemia by Sn-protoporphyrin IX, a potent competitive inhibitor of heme oxidation. Proc Natl Acad Sci USA. 1981;78:6466-6470
3. Yoshinaga T, Sassa S, Kappas A. Purification and properties of bovine spleen heme oxygenase. Amino acid composition and sites of action of inhibitors of heme oxidation. J Biol Chem. 1982;257:7778-7785
4. Kappas A, Simionatto CS, Drummond GS, Sassa S, Anderson KE. The liver excretes large amounts of heme into bile when heme oxygenase is inhibited competitively by Sn-protoporphyrin. Proc Natl Acad Sci USA. 1985;82:896-900
5. Sardana MK, Kappas A. Dual control mechanism for heme oxygenase: tin(IV)-protoporphyrin potently inhibits enzyme activity while markedly increasing content of enzyme protein in liver. Proc Natl Acad Sci USA. 1987;84:2464-2468
6. 14CO generation from radiolabeled endogenous and exogenous heme sources. J Exp Med. 1987; 165:1195-1200
7. 4 vinyl groups of Sn-protoporphyrin to form Sn-mesoporphyrin markedly enhances the ability of the metalloporphyrin to inhibit in vivo heme catabolism. Arch Biochem Biophys. 1987;255:64-74
8. Delaney JK, Mauzerall D, Drummond GS, Kappas A. Photophysical properties of Sn-porphyrins: potential clinical implications. Pediatrics. 1988;81:498-504
9. Kappas A, Drummond GS, Manola T, Petmezaki S, Valaes T. The use of Sn-protoporphyrin in the management of hyperbilirubinemia in newborn infants with direct Coombs-positive ABO incompatibility. Pediatrics. 1988;81:485-497
10. Berglund L, Angelin B, Blomstrand R, Drummond GS, Kappas A. Sn-protoporphyrin lowers serum bilirubin levels, decreases biliary bilirubin output, enhances biliary heme excretion and potently inhibits hepatic heme oxygenase activity in normal human subjects. Hepatology. 1988;8:625-631
11. Galbraith RA, Kappas A. Pharmacokinetics of tin-mesoporphyrin in man and the effects of tin-chelated porphyrins on hyperexcretion of heme pathway precursors in patients with acute inducible porphyria. Hepatology. 1989;9: 882-888
12. Galbraith RA, Drummond GS, Kappas A. Suppression of bilirubin production in the Crigler-Najjar Type I syndrome: studies with the heme oxygenase inhibitor tin-mesoporphyrin. Pediatrics. 1992;89:175-182
13. Valaes T, Petmezaki S, Henschke C, Drummond GS, Kappas A. Control of jaundice in preterm newborns by an inhibitor of bilirubin production: studies with tin-mesoporphyrin. Pediatrics. 1994;93:1-11
14. Kappas A, Drummond GS, Henschke CI, Valaes T. Direct comparison of Sn-mesoporphyrin, an inhibitor of bilirubin production, and phototherapy in controlling hyperbilirubinemia in term and near-term newborns. Pediatrics. 1995;95:468-474
15. Lutton JD, Abraham NG, Drummond GS, Levere RD, Kappas A. Zinc porphyrins: potent inhibitors of hematopoiesis in animal and human bone marrow. Proc Natl Acad Sci USA. 1997;94:1432-1436
16. Valaes T, Drummond GS, Kappas A. Control of hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns using an inhibitor of bilirubin production, Sn-mesoporphyrin. Pediatrics. 1998;101(5). Available at: http://www.pediatrics.org/cgi/content/full/101/5/e1
17. Martinez JC, Garcia HO, Otheguy L, Drummond GS, Kappas A. Control of severe hyperbilirubinemia in full-term newborns with the inhibitor of bilirubin production Sn-mesoporphyrin. Pediatrics. 1999;103:1-5
18. Kappas A, Drummond GS, Valaes TA. Single dose of Sn-mesoporphyrin prevents development of significant hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns. Pediatrics. 2001;108:25-30
19. Kappas A, Drummond GS, Munson DP, Marshall JR. Sn-mesoporphyrin interdiction of severe hyperbilirubinemia in Jehovah's Witness newborns as an alternative to exchange transfusion. Pediatrics. 2001;108:1374-1377
20. Kappas A. Development of heme oxygenase inhibitors for the prevention of severe jaundice in infants. Studies from laboratory bench to newborn nursery. In Abraham NG, Alam J, Nath KA, eds. Heme Oxygenase in Biology and Medicine. Kluwer Academic/Plenum Publishers; 2002:3-17